These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7686207)

  • 1. [Recent progress on therapy of malignant lymphoma].
    Hirano M
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):455-8. PubMed ID: 7686207
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic strategies of highly malignant non-Hodgkin's lymphoma].
    Havemann K; Köppler H; Brittinger G; Steinke B
    Internist (Berl); 1993 Feb; 34(2):139-45. PubMed ID: 8454427
    [No Abstract]   [Full Text] [Related]  

  • 3. [Controversies in therapy of malignant lymphomas].
    Diehl V; Engert A
    Internist (Berl); 1994 Apr; 35(4):313-22. PubMed ID: 8200756
    [No Abstract]   [Full Text] [Related]  

  • 4. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
    Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic strategies of mildly malignant non-Hodgkin's lymphoma].
    Wörmann B; Unterhalt M; Hiddemann W
    Internist (Berl); 1993 Feb; 34(2):132-8. PubMed ID: 8454426
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of recurrent high-grade non-Hodgkin's lymphoma].
    Schmitz N
    Internist (Berl); 1997 Feb; 38(2):143-9. PubMed ID: 9157059
    [No Abstract]   [Full Text] [Related]  

  • 7. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
    Armitage JO
    N Engl J Med; 2005 Mar; 352(12):1250-2. PubMed ID: 15788502
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-hodgkins lymphoma.
    Mead G; Woodcock J; Young C
    Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of malignant lymphomas].
    Luporini G
    Radiol Med; 1976; 62(7-8):553-7. PubMed ID: 95671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of malignant lymphoma with extranodal lesions--current trends and new strategies in chemotherapy].
    Okumura H
    Rinsho Ketsueki; 1999 Mar; 40(3):196-8. PubMed ID: 10222625
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent progress in the chemotherapy program and its theoretical background--malignant lymphoma].
    Hirano M; Okamoto M; Maruyama F; Ezaki K
    Nihon Rinsho; 1992 Jun; 50(6):1393-9. PubMed ID: 1381450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [M-BACOD in advanced case of non-Hodgkin's lymphoma].
    Itami J; Ogata H; Shimizu K; Nemoto K; Yasuda S; Yoshida H; Mikata A; Arimizu N
    Gan No Rinsho; 1990 Mar; 36(4):499-504. PubMed ID: 1690824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical outcomes in low grade follicular lymphoma].
    Yamazaki T; Kura Y; Sato Y; Irie T; Kaneita Y; Mochimaru J; Hanai M; Yasukawa K; Sawada U; Horie T
    Rinsho Ketsueki; 1999 Jan; 40(1):1-8. PubMed ID: 10067089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant lymphomas. Preliminary report of the National Protocol of Antineoplastic Drugs].
    Gutiérrez J; Osorio G; García H; Vacarezza R; Cao C
    Rev Med Chil; 1991 Sep; 119(9):990-1000. PubMed ID: 1726958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
    Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Mounier N; Gisselbrecht C; Lepage E
    N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841320
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
    Klastersky J
    Rev Med Brux; 1982 Apr; 3(4):223-34. PubMed ID: 6178138
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progress in therapeutic strategy for malignant lymphoma].
    Ogura M
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):309-27. PubMed ID: 15791814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.